13
Participants
Start Date
November 30, 2021
Primary Completion Date
April 25, 2023
Study Completion Date
April 25, 2023
Surufatinib in combination with Gemcitabine
Surufatinib in combination with Gemcitabine
UPMC Children's Hospital of Pittsburgh, Pittsburgh
Children's Hospital of Philadelphia, Philadelphia
Children's National Hospital, Washington D.C.
Johns Hopkins University, Baltimore
Children's Hospital of Alabama, Birmingham
Cincinnati Children's Hospital Medical Center, Cincinnati
Riley Hospital for Children, Indianapolis
Washington University School of Medicine, St Louis
The University of Texas Southwestern Medical Center, Dallas
Childrens Hospital Orange County, Orange
Seattle Children's Hospital, Seattle
Lead Sponsor
Hutchmed
INDUSTRY